XML 12 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash $ 13,777 $ 7,405
Trade accounts receivable, net of allowance for doubtful accounts of $303 and $324, respectively 15,012 30,106
Inventories, net 29,746 29,759
Prepaid expenses and other current assets 3,661 3,103
Total current assets 62,196 70,373
Property, plant and equipment, net 22,605 22,525
Goodwill 26,705 26,753
Other intangible assets, net 9,212 9,721
Deferred income taxes, net 12,425 13,222
Other noncurrent assets 2,411 1,963
Total Assets 135,554 144,557
Current Liabilities:    
Accounts payable 8,875 9,388
Current portion of long-term debt 1,537 1,372
Accrued compensation and related benefits 1,258 1,655
Accrued expenses and other current liabilities 5,702 4,775
Total current liabilities 17,372 17,190
Long-term debt 2,190 15,780
Deferred income taxes 480 559
Other noncurrent liabilities 1,675 1,278
Total liabilities 21,717 34,807
Commitments and contingencies (Note 9)
Shareholders' equity:    
Preferred stock – par value $.10 per share; authorized 1,000,000 shares; none issued 0 0
Common stock – par value $.10 per share; authorized 40,000,000 shares; issued – 20,331,348 shares at September 30, 2020 and 20,268,050 shares at December 31, 2019; outstanding – 15,928,055 shares at September 30, 2020 and 15,866,868 shares at December 31, 2019 2,033 2,026
Capital in excess of par value 185,261 184,292
Accumulated deficit (49,706) (52,830)
Accumulated other comprehensive loss (2,619) (2,531)
Treasury stock - at cost; 4,403,293 shares at September 30, 2020 and 4,401,182 shares at December 31, 2019 (21,246) (21,231)
Total Ultralife Corporation equity 113,723 109,726
Non-controlling interest 114 24
Total shareholders’ equity 113,837 109,750
Total liabilities and shareholders' equity $ 135,554 $ 144,557